Literature DB >> 27931161

Swedish Acceptance and Action Questionnaire (SAAQ): a psychometric evaluation.

Tobias Lundgren1,2, Thomas Parling1,3.   

Abstract

Psychological inflexibility and experiential avoidance are equivalent (with somewhat different connotations) concepts and refer to an unwillingness to remain in contact with particular private events. This concept is most often measured by the Acceptance and Action Questionnaire (AAQ-II) and is strongly related to psychopathology and behavioral effectiveness. In this study, the preliminary psychometric properties of the Swedish version of the AAQ-II (Swedish Acceptance and Action Questionnaire-SAAQ) are presented. The study is done in two steps. In the first step, the 10-item version of the AAQ-II is investigated through principal component analysis (n = 147). Secondly, due to problems with the component structure, the instrument is reduced to a six-item version and its validity and internal consistency are investigated (n = 154). The six-item version shows good concurrent and convergent validity as well as satisfying internal consistency (α = .85). Furthermore, the Swedish six-item version of the AAQ-II showed one strong component. Test-retest reliability was satisfactory (r = .80; n = 228). In future research, predictive and external validity would be important to investigate in order to further ensure that the SAAQ is a useful measure for clinical research. In conclusion, the SAAQ has satisfactory psychometric properties, but more data need to be gathered to further explore the possibilities for the instruments in Swedish contexts.

Entities:  

Keywords:  AAQ-II; Acceptance; action; experiential avoidance; psychological flexibility

Mesh:

Year:  2016        PMID: 27931161     DOI: 10.1080/16506073.2016.1250228

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  7 in total

1.  Parents' relationship to pain during children's cancer treatment - a preliminary validation of the Pain Flexibility Scale for Parents.

Authors:  Jenny Thorsell Cederberg; Sandra Weineland Strandskov; JoAnne Dahl; Gustaf Ljungman
Journal:  J Pain Res       Date:  2017-03-03       Impact factor: 3.133

2.  The Values, Acceptance, and Mindfulness Scale for Ice Hockey: A Psychometric Evaluation.

Authors:  Tobias Lundgren; Gustaf Reinebo; Per-Olov Löf; Markus Näslund; Per Svartvadet; Thomas Parling
Journal:  Front Psychol       Date:  2018-10-01

3.  Acceptance and commitment therapy (ACT) for adult type 1 diabetes management: study protocol for a randomised controlled trial.

Authors:  Susanne Amsberg; Ingrid Wijk; Fredrik Livheim; Eva Toft; Unn-Britt Johansson; Therese Anderbro
Journal:  BMJ Open       Date:  2018-11-28       Impact factor: 2.692

4.  Validation of the Swedish version of the Pain Catastrophizing Scale for Parents (PCS-P) for parents of children with cancer.

Authors:  Jenny Thorsell Cederberg; Sandra Weineland; JoAnne Dahl; Gustaf Ljungman
Journal:  J Pain Res       Date:  2019-03-18       Impact factor: 3.133

5.  Efficacy of an Internet-Based Community Reinforcement and Family Training Program to Increase Treatment Engagement for AUD and to Improve Psychiatric Health for CSOs: A Randomized Controlled Trial.

Authors:  Niels EÉk; Karin Romberg; Ola Siljeholm; Magnus Johansson; Sven Andreasson; Tobias Lundgren; Claudia Fahlke; Stina Ingesson; Lisa Bäckman; Anders Hammarberg
Journal:  Alcohol Alcohol       Date:  2020-03-19       Impact factor: 2.826

6.  Study protocol for a feasibility study of an internet-administered, guided, CBT-based, self-help intervention (ENGAGE) for parents of children previously treated for cancer.

Authors:  Joanne Woodford; Anna Wikman; Martin Cernvall; Gustaf Ljungman; Amanda Romppala; Helena Grönqvist; Louise von Essen
Journal:  BMJ Open       Date:  2018-06-14       Impact factor: 2.692

7.  Psychological inflexibility explains distress in parents whose children have chronic conditions.

Authors:  Essi Sairanen; Päivi Lappalainen; Arto Hiltunen
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.